Richard Zordani A.'s most recent trade in Galectin Therapeutics Inc was a trade of 60,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Richard Zordani A. | Director | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 24 Dec 2024 | 10,000 | 42,083 (0%) | 0% | 0.8 | 8,164 | Common Stock |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 22 Aug 2024 | 1,759 | 32,083 (0%) | 0% | 2.3 | 4,046 | Common Stock |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 22 Aug 2024 | 1,000 | 2,000 (0%) | 0% | 2.3 | 2,300 | Common Stock |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 22 Aug 2024 | 741 | 30,324 (0%) | 0% | 2.3 | 1,704 | Common Stock |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 30 Apr 2024 | 1,000 | 1,000 (0%) | 0% | 3.5 | 3,520 | Common Stock |
| Galectin Therapeutics Inc | Zordani Richard A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 28 Jul 2022 | 5,000 | 29,583 (0%) | 0% | 2.5 | 12,500 | Common Stock |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 04 Apr 2022 | 5,000 | 24,583 (0%) | 0% | 1.6 | 8,025 | Common Stock |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 14 Jan 2022 | 5,000 | 19,583 (0%) | 0% | 2.0 | 10,100 | Common Stock |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Richard A. Zordani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 40,000 | 40,000 | - | - | Stock option (right to buy) |